Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Correlation of HIV-specific immunity, viral control, and diversification following planned multiple exposures to autologous HIV in a pediatric population.

Borkowsky W, McFarland EJ, Yogev R, Li Y, Harding P.

Clin Vaccine Immunol. 2011 Oct;18(10):1628-31. doi: 10.1128/CVI.05176-11. Epub 2011 Aug 3.

2.

The frequency of HIV-specific interferon- gamma -producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children.

Buseyne F, Scott-Algara D, Bellal N, Burgard M, Rouzioux C, Blanche S, Riviere Y.

J Infect Dis. 2005 Nov 15;192(10):1781-6. Epub 2005 Oct 7.

3.

Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.

Price DA, Scullard G, Oxenius A, Braganza R, Beddows SA, Kazmi S, Clarke JR, Johnson GE, Weber JN, Phillips RE.

J Virol. 2003 May;77(10):6041-9.

4.

HIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral load.

Nqoko B, Day CL, Mansoor N, De Kock M, Hughes EJ, Hawkridge T, Kaplan G, Boom WH, Hussey GD, Hanekom WA.

AIDS Res Hum Retroviruses. 2011 Dec;27(12):1311-6. doi: 10.1089/aid.2011.0081. Epub 2011 May 12.

5.

Frequency and function of HIV-specific CD8(+) T cells.

Migueles SA, Connors M.

Immunol Lett. 2001 Nov 1;79(1-2):141-50.

PMID:
11595301
6.
7.

Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.

Northfield JW, Loo CP, Barbour JD, Spotts G, Hecht FM, Klenerman P, Nixon DF, Michaëlsson J.

J Virol. 2007 Jun;81(11):5759-65. Epub 2007 Mar 21.

8.

Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia.

Karlsson AC, Younger SR, Martin JN, Grossman Z, Sinclair E, Hunt PW, Hagos E, Nixon DF, Deeks SG.

AIDS. 2004 Apr 30;18(7):981-9.

PMID:
15096800
9.

Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia.

Borkowsky W, Yogev R, Muresan P, McFarland E, Frenkel L, Fenton T, Capparelli E, Moye J, Harding P, Ellis N, Heckman B, Kraimer J.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):401-11. doi: 10.1089/aid.2007.0110.

PMID:
18327977
10.
11.

Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.

Pettersen FO, Taskén K, Kvale D.

Clin Exp Immunol. 2010 Aug;161(2):315-23. doi: 10.1111/j.1365-2249.2010.04179.x. Epub 2010 May 10.

12.

Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.

Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ.

J Infect Dis. 2001 Aug 1;184(3):256-67. Epub 2001 Jul 10.

13.

HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children.

Montesano C, Anselmi A, Palma P, Bernardi S, Cicconi R, Mattei M, Castelli-Gattinara G, Ciccozzi M, Colizzi V, Amicosante M.

New Microbiol. 2010 Oct;33(4):303-9.

14.

Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection.

Cao J, McNevin J, Malhotra U, McElrath MJ.

J Immunol. 2003 Oct 1;171(7):3837-46.

15.

Correlation between HIV-Specific CD8 cell production of interferon- gamma and plasma levels of HIV RNA in perinatally infected pediatric populations.

Borkowsky W, Zhan MX, Chen SH, Ilmet T, Kaul A, Chandwani S, Rigaud M, Essajee S, Gruber C, Freedman A, Krasinski K.

J Infect Dis. 2004 Aug 15;190(4):722-6. Epub 2004 Jul 14.

16.

Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia.

Borkowsky W, Yogev R, Muresan P, McFarland E, Frenkel L, Fenton T, Capparelli E, Moye J, Harding P, Ellis N, Heckman B, Kraimer J.

Vaccine. 2008 Jun 6;26(24):3086-9. doi: 10.1016/j.vaccine.2007.12.017. Epub 2008 Jan 4.

17.

Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells.

Streeck H, Brumme ZL, Anastario M, Cohen KW, Jolin JS, Meier A, Brumme CJ, Rosenberg ES, Alter G, Allen TM, Walker BD, Altfeld M.

PLoS Med. 2008 May 6;5(5):e100. doi: 10.1371/journal.pmed.0050100.

18.

Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.

López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.

Eur J Immunol. 2008 Jun;38(6):1548-58. doi: 10.1002/eji.200738054.

19.
20.

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.

Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, Casazza JP, Koup RA, Picker LJ.

J Virol. 2001 Dec;75(24):11983-91.

Items per page

Supplemental Content

Write to the Help Desk